Frequency-specific auditory brainstem response in infants with normal hearing auditory evoked potentials

OBJETIVO: determinar os níveis mínimos de resposta (NMR) e a latência da onda V em lactentes ouvintes nas frequências de 0.5, 1, 2 e 4 kHz. MÉTODOS: foram avaliados 23 lactentes sem indicadores de risco para deficiência auditiva que apresentavam emissões otoacústicas evocadas por estímulo transiente (EOAET) e potenciais evocados auditivos de tronco encefálico automático (PEATE-A) presentes bilateralmente. RESULTADOS: obtiveram-se NMR médios de 34.2 dBnNA, 25.4 dBnNA, 19 dBnNA e 17.5 dBnNA para as frequências de 0.5, 1, 2 e 4 kHz, respectivamente. Os tempos médios de latência da onda V em 70 e 20 dBnNA, respectivamente, na frequência de 0.5 kHz foram de 10.75 ms e 15.2 ms, em 1 kHz de 8.9 ms e 13.4 ms; de 7.7 ms e 10.2 ms em 2 kHz, e para 4 kHz foram de 7.3 ms e 9.4 ms. CONCLUSÃO: os valores encontrados podem ser utilizados na prática clínica para orientar o diagnóstico diferencial da perda auditiva, complementando a avaliação auditiva de lactentes.PURPOSE: to determine the ABR thresholds and the latency of V wave in hearing infants at the frequencies: 0.5, 1, 2 and 4 kHz. METHODS: 23 infants with no risk factors concerning hearing loss that had transient otoacoustic emissions (TOAE) and automatic auditory brainstem response (A-ABR), bilaterally present, were evaluated. RESULTS: ABR thresholds were obtained in average, namely: 34.2 dBHL, 25.4 dBHL, 19 dBHL and 17.5 dBHL for frequencies of 0.5, 1, 2 and 4 kHz, respectively. The mean latency of V wave at 70 and 20 dBHL, respectively, at a 0.5 kHz frequency were 10.75 ms and 15.2 ms, 1 kHz 8.9 ms and 13.4 ms; 7.7 ms and 10.2 ms at 2 kHz, and as for4 kHz they were 7.3 ms and 9.4 ms. CONCLUSIONS: the found values can be used in clinical practice in order to guide the differential diagnosis of hearing loss, complementing the evaluation as for hearing infants

Etiological investigation of deafness in neonates screened in a universal newborn hearing screening program

Purpose to describe the results of etiology of deaf in neonates screened in a universal newborn hearing screening program. Methods a descriptive, cross-sectional and prospective study. The study included all newborns diagnosed with hearing loss identified in a universal newborn hearing screening program from August 2003 to December 2006. The etiology of deaf was determined after detailed anamnesis performed by the otorhinolaryngologist; survey of serological tests for toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis and HIV; tomography of the temporal bone and genetic tests. Results 17 neonates were diagnosed with hearing loss in the period studied. 64.7% of cases presented as probable causes prenatal etiology, 29.4% perinatal causes and one child (5.9%) had unknown etiology. Of prenatal causes, 36.4% had confirmed genetic origin and 36.4% presumed etiology of heredity. We confirmed the presence of congenital infections in 18.2% of cases and one child (9%) had craniofacial anomalies as a possible etiology. The degree of hearing loss more frequently observed in the subjects studied was the profound (47.1%). Conclusion the increased occurrence of etiologies in this study was of prenatal origin, followed by perinatal origin.Objetivo descrever os resultados da investigação etiológica da deficiência auditiva realizada em neonatos rastreados em um programa de triagem auditiva neonatal universal. Métodos estudo descritivo, transversal e prospectivo. Foram incluídos no estudo todos os neonatos diagnosticados com deficiência auditiva identificados em um programa de triagem auditiva neonatal universal no período de agosto de 2003 a dezembro de 2006. A provável etiologia da deficiência auditiva foi determinada após anamnese detalhada realizada pelo médico otorrinolaringologista; pesquisa das sorologias para toxoplasmose, rubéola, citomegalovírus, herpes, sífilis e HIV; tomografia dos ossos temporais e exames genéticos. Resultados foram diagnosticados 17 sujeitos com deficiência auditiva no período estudado. 64.7% dos casos estudados apresentaram como provável etiologia causas pré-natais, 29.4% causas peri-natais e um sujeito (5,9%) apresentou etiologia desconhecida. Das causas pré-natais, 36.4% tiveram origem genética confirmada e 36.4% etiologia presumida de hereditariedade. Foi confirmada a presença de infecções congênitas em 18.2% dos casos e um sujeito (9%) apresentou anomalia craniofacial como provável etiologia. O grau de perda auditiva mais frequente observado nos sujeitos estudados foi o profundo (47,1%). Conclusão a maior ocorrência de etiologias observada neste estudo foram as de origem pré-natal, seguida das de origem peri-natal.42242

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Background Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. Methods We used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For schoolaged children and adolescents, we report thinness (BMI <2 SD below the median of the WHO growth reference) and obesity (BMI >2 SD above the median). Findings From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries (6%) for women and 17 (9%) for men with a posterior probability of at least 0·80 that the observed changes were true decreases. The combined prevalence increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0·80. In 2022, the combined prevalence of underweight and obesity was highest in island nations in the Caribbean and Polynesia and Micronesia, and countries in the Middle East and north Africa. Obesity prevalence was higher than underweight with posterior probability of at least 0·80 in 177 countries (89%) for women and 145 (73%) for men in 2022, whereas the converse was true in 16 countries (8%) for women, and 39 (20%) for men. From 1990 to 2022, the combined prevalence of thinness and obesity decreased among girls in five countries (3%) and among boys in 15 countries (8%) with a posterior probability of at least 0·80, and increased among girls in 140 countries (70%) and boys in 137 countries (69%) with a posterior probability of at least 0·80. The countries with highest combined prevalence of thinness and obesity in school-aged children and adolescents in 2022 were in Polynesia and Micronesia and the Caribbean for both sexes, and Chile and Qatar for boys. Combined prevalence was also high in some countries in south Asia, such as India and Pakistan, where thinness remained prevalent despite having declined. In 2022, obesity in school-aged children and adolescents was more prevalent than thinness with a posterior probability of at least 0·80 among girls in 133 countries (67%) and boys in 125 countries (63%), whereas the converse was true in 35 countries (18%) and 42 countries (21%), respectively. In almost all countries for both adults and school-aged children and adolescents, the increases in double burden were driven by increases in obesity, and decreases in double burden by declining underweight or thinness. Interpretation The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa. A healthy nutrition transition that enhances access to nutritious foods is needed to address the remaining burden of underweight while curbing and reversing the increase in obesit

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Presença de microfonismo coclear no peate-clique: diagnóstico diferencial entre espectro da neuropatia auditiva e perdas auditivas cocleares descendentes em crianças Presence of cochlear microphonics in click-ABR: differential diagnosis between auditory neuropathy spectrum disorder and steeply sloping cochlear hearing loss in children

TEMA: diagnóstico diferencial entre espectro da neuropatia auditiva e perdas auditivas cocleares descendentes em crianças com presença de microfonismo coclear no PEATE-clique. PROCEDIMENTOS: este relato de caso descreve os resultados da avaliação audiológica de duas crianças atendidas no Centro "Audição na Criança" da Divisão de Educação e Reabilitação dos Distúrbios da Comunicação da Pontifícia Universidade Católica de São Paulo (CeAC/DERDIC/PUCSP) que apresentaram microfonismo coclear no registro do PEATE-clique. As crianças foram submetidas às avaliações utilizando-se o PEATE-clique, o registro das emissões otoacústicas e a avaliação audiológica tonal, com a técnica da Audiometria de Reforço Visual. RESULTADOS: as avaliações comportamental, eletroacústica e eletrofisiológica revelaram que as crianças apresentam perda auditiva sensorioneural (coclear) com configuração descendente, de modo que a presença do microfonismo coclear no registro do PEATE-clique era provavelmente gerada pela preservação da cóclea nas frequências baixas. CONCLUSÃO: os casos apresentados mostram que na ausência das emissões otoacústicas e presença do microfonismo coclear, não se deve interpretar isoladamente cada exame, para que não ocorram equívocos no diagnóstico, que pode ser confundido com o Espectro da Neuropatia Auditiva. O microfonismo coclear pode aparecer em outras condições, tais como em perdas auditivas cocleares descendentes.<br>BACKGROUND: differential diagnosis between auditory neuropathy spectrum disorder andsteeply sloping cochlear hearing loss in children with presence of cochlear microphonics for click-ABR. PROCEDURES: this case report describes the results of the audiological evaluation for two children assisted at Centro "Audição na Criança" of Divisão de Educação e Reabilitação dos Distúrbios da Comunicação of Pontifícia Universidade Católica of São Paulo (CeAC/DERDIC/PUCSP) with presence of cochlear microphonics for click-ABR. The children are assessed by click-ABR, otoacoustic emissions and pure tone audiological evaluation, using the Visual Reinforcement Audiometry technique. RESULTS: the test battery showed that children have sensorineural hearing loss (cochlear) with steeply sloping configuration, so that the presence of cochlear microphonics in the click-ABR was probably generated by the preservation of the cochlea in the low frequencies. CONCLUSION: the cases demonstrated that the absence of the otoacustic emissions, and presence of cochlear microphonics should not be interpreted as Auditory Neuropathy Spectrum Disorder, since that these conditions are similar to steeply sloping cochlear hearing loss

Potenciais Evocados Auditivos de Estado Estável no diagnóstico audiológico infantil: uma comparação com os Potenciais Evocados Auditivos de Tronco Encefálico Steady-state auditory evoked responses in audiological diagnosis in children: a comparison with brainstem evoked auditory responses

Os Potenciais Evocados Auditivos de Estado Estável (PEAEE) têm sido apontados como uma técnica promissora na avaliação audiológica infantil. OBJETIVO: Investigar o nível de concordância entre os resultados dos PEAEE e dos Potenciais Evocados Auditivos de Tronco Encefálico (PEATE-clique) em um grupo de crianças com perda auditiva sensorioneural, averiguando assim a aplicabilidade clínica desta técnica na avaliação audiológica infantil. FORMA DE ESTUDO: Clínico prospectivo de coorte transversal. MATERIAL E MÉTODO: 15 crianças com idade entre dois e 36 meses e diagnóstico de perda auditiva sensorioneural. A concordância entre as respostas dos dois testes foi avaliada por meio do coeficiente de correlação intraclasse e o teste de McNemar comparou os dois testes quanto à probabilidade de ocorrência de resposta. RESULTADOS: Os coeficientes de correlação encontrados foram 0,70; 0,64; 0,49; 0,69; 0,63 e 0,68 respectivamente para as frequências de 1, 2, 4, 1-2, 2-4 e 1-2-4kHz. No teste de McNemar foi obtido p=0.000, indicando que a probabilidade de se obter resposta presente nos dois testes não é igual, sendo maior nos PEAEE. CONCLUSÃO: A boa concordância observada entre as técnicas sugere que um exame pode ser complementar ao outro. Os PEAEE, entretanto, promoveram informações adicionais nos casos de perdas severas e profundas, acrescentando dados importantes para a reabilitação destas crianças e proporcionando maior precisão no diagnóstico audiológico.<br>Auditory Steady-State Responses (ASSR) are being recognized as a promising technique in the assessment of hearing in children. AIM: To investigate the agreement level between results obtained from ASSR and click-ABR in a group of children with sensorineural hearing loss, in order to study the clinical applicability of this technique to evaluate the hearing status in young children. STUDY DESIGN: clinical prospective with a cross-sectional cohort. MATERIALS AND METHODS: 15 children aged between two and 36 months and with diagnosis of sensorineural hearing loss. The correlation between the responses of the two tests was evaluated by intraclass correlation coefficient and McNemar test comparing the probability of responses in both tests. RESULTS: The correlation coefficients were: 0.70; 0.64; 0.49; 0.69; 0.63 and 0.68 respectively for frequencies of 1, 2, 4, 1-2, 2-4 and 1-2-4kHz. In McNemar test p = 0.000, indicating that the probability of obtaining responses in both tests was not equal, but greater for the ASSR. CONCLUSION: we found good agreement between the techniques among the four frequencies evaluated, suggesting that both tests may be complementary. However, the ASSR was able to obtain additional information in cases of severe and profound hearing losses, adding important data to the management of these children, providing greater accuracy to the audiological diagnosis